Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,648 INR | +0.78% | +0.82% | +2.72% |
May. 14 | Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505 | MT |
May. 13 | Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6% | MT |
Sales 2024 | 22.27B 267M | Sales 2025 * | 24.98B 299M | Capitalization | 220B 2.64B |
---|---|---|---|---|---|
Net income 2024 | 3.58B 42.88M | Net income 2025 * | 4.18B 50.07M | EV / Sales 2024 | 8.44 x |
Net cash position 2024 * | 7.68B 92.08M | Net cash position 2025 * | 10.03B 120M | EV / Sales 2025 * | 8.4 x |
P/E ratio 2024 |
52.6
x | P/E ratio 2025 * |
53
x | Employees | 4,048 |
Yield 2024 * |
0.64% | Yield 2025 * |
0.83% | Free-Float | 43.38% |
Latest transcript on Dr. Lal PathLabs Limited
1 day | +0.78% | ||
1 week | +0.82% | ||
1 month | +11.61% | ||
3 months | +12.59% | ||
6 months | -1.85% | ||
Current year | +2.72% |
Managers | Title | Age | Since |
---|---|---|---|
Shankha Banerjee
CEO | Chief Executive Officer | - | 14-06-30 |
Ved Prakash Goel
DFI | Director of Finance/CFO | - | 05-12-31 |
Arvind Lal
CHM | Chairman | 74 | 95-02-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 58 | 23-07-26 | |
Director/Board Member | 77 | 15-08-20 | |
Arvind Lal
CHM | Chairman | 74 | 95-02-13 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.10% | 6 M€ | +6.07% | - | |
0.01% | 4 M€ | -4.41% | - | |
0.01% | 112 M€ | +4.61% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 2,648 | +0.78% | 215,608 |
24-05-30 | 2,627 | -1.01% | 151,205 |
24-05-29 | 2,654 | +1.41% | 166,094 |
24-05-28 | 2,617 | -0.58% | 105,942 |
24-05-27 | 2,632 | +0.23% | 109,773 |
Delayed Quote NSE India S.E., May 31, 2024 at 07:43 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.72% | 2.63B | |
-24.16% | 7.76B | |
+68.65% | 4.33B | |
-2.98% | 2.64B | |
-46.17% | 2.16B | |
-22.12% | 1.46B | |
+13.62% | 1.17B | |
-43.81% | 1.14B | |
+20.41% | 999M | |
-9.27% | 955M |
- Stock Market
- Equities
- LALPATHLAB Stock